Study guide

13.2 Disseminated Intravascular Coagulation (DIC) & Trauma-Induced Coagopathy (TIC)

BCEN TCRN Trauma Certified Registered Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Head & Neck Trauma I - Traumatic Brain Injury & ICP

1.1 Primary vs. Secondary Brain Injury & Pathophysiology 1.2 Intracranial Pressure (ICP) Monitoring & Monroe-Kellie Doctrine 1.3 Cerebral Perfusion Pressure (CPP) & Medical Management of Elevated ICP 1.4 Herniation Syndromes & Acute Surgical TBI Interventions

2 Chapter 2: Head & Neck Trauma II - Maxillofacial, Ocular & Spinal Cord Trauma

2.1 Maxillofacial Trauma & Airway Management (Le Fort & Mandibular Fractures) 2.2 Ocular Trauma Assessment & Emergency Interventions 2.3 Penetrating & Blunt Neck Trauma (Zone I-III Management) 2.4 Cervical & Upper Spinal Cord Injury (Neurogenic Shock vs. Spinal Shock & ASIA Scale)

3 Chapter 3: Thoracic Trauma I - Immediate Life-Threatening Airway & Chest Injuries

3.1 Tension Pneumothorax, Simple Pneumothorax & Needle Decompression 3.2 Open Pneumothorax & Massive Hemothorax Management 3.3 Cardiac Tamponade & Resuscitative Thoracotomy Indications 3.4 Tracheobronchial Disruption & Flail Chest with Pulmonary Contusion

4 Chapter 4: Thoracic Trauma II - Vascular, Parenchymal & Diaphragmatic Injuries

4.1 Blunt Cardiac Injury (BCI) & Myocardial Contusion Monitoring 4.2 Traumatic Aortic Disruption (TAD) & Great Vessel Injury 4.3 Esophageal Perforation & Penetrating Thoracic Trauma 4.4 Diaphragmatic Rupture & Thoracic Surgical Indications

5 Chapter 5: Abdominal Trauma - Solid Organ, Hollow Viscus & Abdominal Compartment Syndrome

5.1 Hepatic & Splenic Trauma Grading & Non-Operative Management 5.2 Hollow Viscus & Mesenteric Injury (Bowel Perforation & Peritonitis) 5.3 FAST Exam, Diagnostic Peritoneal Lavage (DPL) & Abdominal CT Indications 5.4 Retroperitoneal Hemorrhage & Abdominal Compartment Syndrome (ACS)

6 Chapter 6: Pelvic & Genitourinary Trauma

6.1 Pelvic Fracture Classification & Biomechanical Instability 6.2 Acute Pelvic Hemorrhage Control (Pelvic Binders, Angiography & REBOA) 6.3 Bladder & Urethral Trauma (High-Riding Prostate & Retrograde Urethrography) 6.4 Renal & Ureteral Trauma Management

7 Chapter 7: Musculoskeletal Extremity Trauma & Compartment Syndrome

7.1 Open Fractures & Gustilo-Anderson Classification 7.2 Traumatic Amputations & Mangled Extremity Severity Score (MESS) 7.3 Extremity Vascular Injury (Hard vs. Soft Signs & Ankle-Brachial Index) 7.4 Compartment Syndrome & Fasciotomy Indications

8 Chapter 8: Wound Care, Soft Tissue & Burn Trauma

8.1 Soft Tissue Trauma, Crush Injury & Rhabdomyolysis 8.2 Burn Depth Assessment & Total Body Surface Area (TBSA) Calculation 8.3 Parkland Formula & Fluid Resuscitation Protocols for Burns 8.4 Inhalation Injury, Escharotomy & Burn Wound Care

9 Chapter 9: Special Populations I - Pediatric & Geriatric Trauma

9.1 Pediatric Trauma Airway, Breathing & Physiologic Differences 9.2 Pediatric Fluid Resuscitation, Vital Signs & Child Abuse/NAT Recognition 9.3 Geriatric Trauma Physiology, Frailty & Medication Effects (Anticoagulants/Beta Blockers) 9.4 Geriatric Rib Fractures, Fall Mechanisms & Traumatic Brain Injury

10 Chapter 10: Special Populations II - Pregnancy, Bariatric & Vulnerable Populations

10.1 Pregnant Trauma Patient Physiologic Adaptation & Supine Hypotensive Syndrome 10.2 Fetal Assessment, Kleihauer-Betke Test & Perimortem Cesarean Delivery 10.3 Bariatric Trauma Considerations & Airway/Resuscitation Challenges 10.4 Intimate Partner Violence, Human Trafficking & Substance Use in Trauma

11 Chapter 11: Initial Trauma Assessment & Airway Management

11.1 Triage Systems & Trauma Center Levels I-IV 11.2 Primary Survey (ABCDE) & Rapid Trauma Assessment 11.3 Airway Management & Rapid Sequence Intubation (RSI) in Trauma 11.4 Secondary Survey (FGHIJ) & AMPLE History Collection

12 Chapter 12: Trauma Shock & Damage Control Resuscitation

12.1 Pathophysiology & Classification of Shock in Trauma 12.2 Massive Transfusion Protocol (MTP) & Balanced 1:1:1 Blood Product Resuscitation 12.3 Viscoelastic Hemostatic Assays (TEG/ROTEM) & Tranexamic Acid (TXA) 12.4 Damage Control Resuscitation, Permissive Hypotension & Lethal Triad Prevention

13 Chapter 13: Post-Resuscitation Critical Care & Complications

13.1 Acute Respiratory Distress Syndrome (ARDS) in Trauma 13.2 Disseminated Intravascular Coagulation (DIC) & Trauma-Induced Coagopathy (TIC) 13.3 Systemic Inflammatory Response Syndrome (SIRS), Sepsis & MODS 13.4 Invasive Hemodynamic Monitoring & Hypothermia Prevention

14 Chapter 14: Rehabilitation, Psychosocial Support & Transition of Care

14.1 Acute Stress Response, PTSD Screening & Trauma Psychosocial Support 14.2 Family-Centered Care & End-of-Life/Brain Death Determination 14.3 Organ Donation Protocols & Donor Management in Trauma 14.4 Inter-Facility Transfer Protocols (EMTALA/COBRA) & Discharge Planning

15 Chapter 15: Professional Practice, Quality & Disaster Management

15.1 Trauma Registry & Performance Improvement and Patient Safety (PIPS) 15.2 Mass Casualty Triage (START/JumpSTART) & Incident Command System (ICS) 15.3 Legal, Ethical & Forensic Evidence Preservation in Trauma Nursing 15.4 Secondary Traumatic Stress, Nurse Resilience & Team Well-being

13.2 Disseminated Intravascular Coagulation (DIC) & Trauma-Induced Coagopathy (TIC)

Key Takeaways Explain This Topic AI

The Lethal Triad of trauma (hypothermia, acidosis, coagulopathy) is expanded to the Diamond of Death by adding hypocalcemia (ionized calcium < 1.1-1.2 mmol/L).

Trauma-Induced Coagopathy (TIC) is driven early by shock-induced hypoperfusion, endothelial dysfunction, and hyperfibrinolysis, unlike DIC which is driven by tissue factor release and microvascular thrombosis.

Viscoelastic testing (TEG/ROTEM) provides real-time functional clot assessment: R time guides FFP, K time/alpha-angle guide Cryoprecipitate, MA guides Platelets, and LY30 guides TXA.

Tranexamic Acid (TXA) must be administered within 3 hours of injury (1g over 10 min, then 1g over 8 hours) to reduce mortality from severe traumatic hemorrhage.

Last updated: July 2026

13.2 Disseminated Intravascular Coagulation (DIC) & Trauma-Induced Coagopathy (TIC)

Clinical Summary: Trauma-Induced Coagopathy (TIC) is an immediate, endogenous impairment of clot formation driven by shock, tissue hypoperfusion, and endothelial activation, whereas Acute DIC involves systemic microvascular thrombosis and consumption coagulopathy. Management requires rapid goal-directed hemostatic resuscitation using Thrombelastography (TEG/ROTEM), 1:1:1 balanced transfusion, early Tranexamic Acid (TXA), and ionized calcium correction.

Coagulopathy in the severely injured trauma patient is a major driver of preventable mortality. Historically attributed solely to hemodilution and hypothermia, research has identified Trauma-Induced Coagopathy (TIC) as an immediate, biologically complex phenotype distinct from classical Disseminated Intravascular Coagulation (DIC) . The TCRN must understand the pathophysiologic differences, advanced point-of-care viscoelastic testing, and goal-directed blood component therapy.

  • Pathophysiology: TIC vs. Acute DIC
  • The Diamond of Death

Severe hemorrhage initiates a lethal spiral. The classic "Lethal Triad" of trauma—Hypothermia, Acidosis, and Coagulopathy—has been expanded to the Diamond of Death by recognizing Hypocalcemia as an independent primary driver. [Hypothermia]

  • / \
  • [Acidosis] ─── [Coagulopathy]
  • \ /
  • [Hypocalcemia]

Hypothermia (< 35°C): Impairs platelet function and inhibits enzymatic clotting factor activity (clotting factor activity drops ~10% per 1°C core temp decline).

Acidosis (pH < 7.20): Inhibits coagulation factor complex assembly on lipid surfaces; factor Xa/Va activity is reduced by 50% at pH 7.10.

Hypocalcemia ( i C a 2 + < 1.1 mmol/L iCa^{2+} < 1.1 \text{ mmol/L} i C a 2 + < 1.1 mmol/L ): Calcium (Factor IV) is an essential cofactor in almost every step of the coagulation cascade and platelet cross-linking.

Coagulopathy: Exacerbates ongoing microvascular bleeding, amplifying hypoperfusion, hypothermia, and acidosis.

Trauma-Induced Coagopathy (TIC) Pathophysiology

TIC develops within minutes of severe injury before significant fluid resuscitation occurs. It is driven by two principal mechanisms: severe tissue injury and shock-induced tissue hypoperfusion .

Activated Protein C (APC) Pathway: Hypoperfusion causes endothelial hypoxia, triggering thrombomodulin-thrombin complex formation. This activates Protein C, which consumes and inactivates Factors Va and VIIIa while neutralizing Plasminogen Activator Inhibitor-1 (PAI-1). Uninhibited tissue plasminogen activator (tPA) induces rapid hyperfibrinolysis .

Endothelial Glycocalyx Degradation: Shock causes shedding of the endothelial glycocalyx layer, releasing heparin-like glycosaminoglycans into circulation ("endogenous heparinization").

Platelet Dysfunction: Trauma induces profound platelet exhaustion and impaired aggregation, even when total platelet counts appear normal.

Comparison: TIC vs. Acute DIC

  • Feature Trauma-Induced Coagopathy (TIC) Acute Disseminated Intravascular Coagulation (DIC)
  • Primary Trigger Tissue trauma + hypoperfused shock state Massive systemic exposure of Tissue Factor (TF)
  • Microvascular State Early hypocoagulability & hyperfibrinolysis Widespread microvascular thrombosis

Fibrinolysis Pattern Rapid early hyperfibrinolysis (tPA surge) Secondary fibrinolysis following widespread clotting

Clinical Presentation Profuse microvascular bleeding, surgical oozing Dual presentation: Organ ischemia (early) & severe hemorrhage (late)

  • Fibrinogen Levels Decreases rapidly due to hyperfibrinolysis Progressively consumed during systemic clotting
  • Laboratory Evaluation & Viscoelastic Testing

Traditional coagulation tests—Prothrombin Time (PT/INR), activated Partial Thromboplastin Time (aPTT), and Platelet count—have significant limitations in trauma. They are performed on cell-free plasma incubated at 37°C, taking 45–60 minutes to return, failing to reflect true in vivo cellular and temperature-dependent coagulation.

Traditional Coagulation Thresholds in Trauma

Fibrinogen: Normal 200–400 mg/dL. Critical threshold in trauma: < 150–200 mg/dL requires urgent replacement with cryoprecipitate or fibrinogen concentrate.

Platelets: Target > 50 , 000 / μ L > 50,000/\mu\text{L} > 50 , 000/ μ L in ongoing hemorrhage, > 100 , 000 / μ L > 100,000/\mu\text{L} > 100 , 000/ μ L in severe traumatic brain injury.

PT/INR & aPTT: INR > 1.5 > 1.5 > 1.5 or aPTT > 1.5 × > 1.5 \times > 1.5 × control indicates significant factor depletion requiring plasma.

Viscoelastic Hemostatic Assays (TEG and ROTEM)

Viscoelastic point-of-care testing— Thrombelastography (TEG) and Rotational Thromboelastometry (ROTEM) —evaluates whole-blood clot formation, strength, and lysis in real-time within 10–15 minutes. TEG Trace Morphology:

  • R time K Alpha Angle (α)
  • |------| |---| /
  • ~~~~~~~\ /~~~~~~~/
  • X / Maximum Amplitude (MA)
  • ~~~~~~~~/ \~~~~~~~/ |====================|
  • \
  • \____________________ LY30 (%)

TEG Parameters and Targeted Therapy:

Parameter Reference Range Physiological Meaning Deficit Indicated Targeted Intervention

R time (Reaction Time) 5–10 min Time to initial fibrin formation Coagulation factor deficiency Fresh Frozen Plasma (FFP) or PCC

K time & α \alpha α -Angle K: 1–3 min; α \alpha α : 53–72° Speed of clot kinetics & fibrin buildup Fibrinogen deficiency / sluggish kinetics Cryoprecipitate or Fibrinogen Concentrate

MA (Maximum Amplitude) 50–70 mm Absolute clot strength (80% platelets, 20% fibrin) Platelet dysfunction or thrombocytopenia Platelets (1 unit pool) ± \pm ± Desmopressin (DDAVP)

LY30 (Lysis at 30 min) 0–3% Percentage of clot lysis 30 min post-MA Hyperfibrinolysis (tPA surge) Tranexamic Acid (TXA)

ROTEM Equivalent Terms: R time = C T R\text{ time} = CT R time = CT (Clotting Time); K time = C F T K\text{ time} = CFT K time = CFT (Clot Formation Time); M A = M C F MA = MCF M A = MCF (Maximum Clot Firmness); L Y 30 = M L LY30 = ML L Y 30 = M L (Maximum Lysis).

Targeted Hemostatic Resuscitation Protocols

Modern resuscitation of severe hemorrhagic shock relies on Damage Control Resuscitation (DCR) to prevent worsening TIC.

1. Massive Transfusion Protocol (MTP)

Balanced Transfusion Ratio: Administer Packed Red Blood Cells (PRBCs), Fresh Frozen Plasma (FFP), and Platelets in a fixed 1:1:1 ratio to mimic whole blood transfusion and prevent dilutional coagulopathy.

Avoid Crystalloids: Limit isotonic crystalloid administration ( < 1 – 1.5 L < 1\text{--}1.5 \text{ L} < 1 – 1.5 L ) because crystalloids dilute clotting factors, degrade the glycocalyx, and worsen hypothermic acidosis.

2. Tranexamic Acid (TXA) Administration

TXA is a synthetic lysine analog that competitively inhibits plasminogen activation, blocking fibrin breakdown.

CRASH-2 Protocol: Administer 1 gram IV loading dose over 10 minutes within 3 hours of injury, followed by a continuous 1 gram IV infusion over 8 hours .

Timing Warning: TXA administered > 3 hours > 3 \text{ hours} > 3 hours post-injury is ineffective and increases mortality due to pro-thrombotic side effects and late hypofibrinolytic shift.

3. Fibrinogen Replacement & Ionized Calcium Management

Cryoprecipitate: Administer 10 units (or 2 – 3 g 2\text{--}3 \text{ g} 2 – 3 g fibrinogen concentrate) for fibrinogen < 150 – 200 mg/dL < 150\text{--}200 \text{ mg/dL} < 150 – 200 mg/dL or TEG α \alpha α -angle < 53 ∘ < 53^\circ < 5 3 ∘ .

Ionized Calcium Correction: Citrate preservative in blood products chelates ionized calcium. Monitor i C a 2 + iCa^{2+} i C a 2 + every 30 minutes during MTP. Administer 1–2 grams Calcium Chloride (or Calcium Gluconate) IV to maintain i C a 2 + > 1.1 – 1.2 mmol/L iCa^{2+} > 1.1\text{--}1.2 \text{ mmol/L} i C a 2 + > 1.1 – 1.2 mmol/L .